PATENT CLAIM ANALYSIS

Application Number: 16026609
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "04400A"]

Abstract:
The invention provides siRNA compositions that specifically downregulates expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD).

Claim (Index 9):
The composition according to  claim 8 , wherein the lipid is a bile acid.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 95.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15614147', '15670132', '15917990', '12903558', '13057443']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7504944389931544
- 35 USC 102 Novelty (BERT): 0.5550819945875426
- Combined Prediction Score: 0.7309531945525932
- Mean Citation Score: 223.80796400000003
- Max Citation Score: 420.91812
- Similarity Product: 296.0197210882044

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test